Vancomycin + Linezolid
ApprovedCompleted 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Pneumonia, Ventilator-Associated
Conditions
Pneumonia, Ventilator-Associated
Trial Timeline
Nov 1, 2002 → Jan 1, 2005
NCT ID
NCT00572559About Vancomycin + Linezolid
Vancomycin + Linezolid is a approved stage product being developed by Pfizer for Pneumonia, Ventilator-Associated. The current trial status is completed. This product is registered under clinical trial identifier NCT00572559. Target conditions include Pneumonia, Ventilator-Associated.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00572559 | Approved | Completed |
Competing Products
20 competing products in Pneumonia, Ventilator-Associated